Early-Stage Non-Small-Cell Lung Cancer

MADRID — In this video, Julia Rotow, MD, highlighted positive OS data from the KEYNOTE-671 study of a perioperative pembrolizumab regimen for early-stage non-small-cell lung cancer presented at ESMO Congress.

In this video, Erminia Massarelli, MD, PhD, MS, co-director of the lung cancer and thoracic oncology program, and associate professor in the department of medical oncology and therapeutics research at City of Hope Cancer Center in Duarte, California, highlights treatment options for EGFR-mutated lung cancer.